Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice

Allergologia et Immunopathologia

Volumn 39, Issue 3, 2011, Pages 122-127

  Ferres J ^a   Justicia, J L ^b   Garcia M P ^a   Munoz Tuduri M ^b   Alva V ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Sant Joan Despi   (Spain)

Author keywords

Allergen immunotherapy; Asthma; House dust mites; Rhinitis; SLIT

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IMMUNOMODULATING AGENT; MONTELUKAST; STALLERGEN; STEROID;

ABDOMINAL PAIN; ALLERGIC RHINITIS; ANAPHYLACTIC SHOCK; ARTICLE; ASTHMA; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HEADACHE; HOUSE DUST ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; NONHUMAN; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; SUBLINGUAL IMMUNOTHERAPY; TONGUE EDEMA; TONGUE ULCER; VISUAL ANALOG SCALE;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; PYROGLYPHIDAE; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL;

EID: 79956120706     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2010.01.008     Document Type: Article

References (25)

1. Malling H.J. Immunotherapy as an effective tool in allergy treatment. Allergy 1998, 53:461-472.
2. Bousquet J., Lockey R., Malling H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998, 81:401-405.
3. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108(5 Supl 1):147-334.
4. Novembre E., Galli E., Landi F., Caffarelli C., Pifferi M., De Marco E. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004, 114:851-857.
5. Alvarez-Cuesta E., Bousquet J., Canonica G.W., Durham S.R., Malling H.J., Valovirta E. Standards for practical allergen-specific immunotherapy. Allergy 2006, 61(Supl 82):1-20.
6. Pajno G.B., Barberio G., De Luca F., Morabito L., Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001, 31:1392-1397.
7. Jacobsen L., Niggemann B., Dreborg S., Ferdousi H.A., Halken S., Host A., et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007, 62:943-948.
8. Amin H.S., Liss G.M., Bernstein D.I. Evaluation of near-fatal reactions to allergen immunotherapy injections. The Journal of Allergy and Clinical Immunology 2006, 117:169-175.
9. Bernstein D.I., Wanner M., Borish L., Liss G.M. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. The Journal of Allergy and Clinical Immunology 2004, 113:1129-1136.
10. Wilson D.R., Lima M.T., Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005, 60:4-12.
11. Wahn U., Tabar A., Kuna P., Halken S., Montagut A., de Beaumont O., et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009, 123:160-166.
12. Bufe A., Eberle P., Franke-Beckmann E., Funck J., Kimmig M., Klimek L., et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009, 123:167-173.
13. Tari M.G., Mancino M., Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990, 18:277-284.
14. Penagos M., Compalati E., Tarantini F., Baena-Cagnani R., Huerta J., Passalacqua G., et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006, 97:141-148.
15. Passalacqua G., Durham S.R. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007, 119:881-891.
16. Larenas-Linnemann D. Certainties and doubts about sublingual and oral immunotherapy in children. Curr Opin Allergy Clin Immunol 2009, 9:558-567.
17. Hirsch T., Sahn M., Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997, 8:21-27.
18. Bahceciler N.N., Isik U., Barlan I.B., Basaran M.M. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001, 32:49-55.
19. Marogna M., Tomassetti D., Bernasconi A., Colombo F., Massolo A., Businco A.D., et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008, 101:206-211.
20. Frati F., Incorvaia C., Marcucci F., Sensi L., Di Cara G., Puccinelli P., et al. Dose dependence of efficacy but not of safety in sublingual immunotherapy. Monaldi Arch Chest Dis 2006, 65:38-40.
21. Di Rienzo V., Marcucci F., Puccinelli P., Parmiani S., Frati F., Sensi L., et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003, 33:206-210.
22. Lue K.H., Lin Y.H., Sun H.L., Lu K.H., Hsieh J.C., Chou M.C. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 2006, 17:408-415.
23. Niu C.K., Chen W.Y., Huang J.L., Lue K.H., Wang J.Y. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. Respir Med 2006, 100:1374-1383.
24. Ozdemir C., Yazi D., Gocmen I., Yesil O., Aydogan M., Semic-Jusufagic A., et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol 2007, 18:508-515.
25. Pham-Thi N., Scheinmann P., Fadel R., Combebias A., Andre C. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007, 18:47-57.